SLC5A2 and diabetes mellitus: The potential mechanisms of the blood pressure decrease caused by SGLT2 inhibition in diabetes were postulated to be improved glucose control, weight loss, volume contraction due to osmotic diuresis, and improved arterial stiffness [19].